Podcast Index
Explora podcasts por categoría, abre episodios recientes y descarga audio para escucharlo sin conexión.
Nota Bene
Benjamin Brillaud
Glücklich trotz Geld
Mathias Böttcher
Innovating Clinical Trials
Liam Eves and Ted Trafford
The Wild Idea
Wild Idea Media
Star Wars Reactions
Aaron Harris
Ö1 Wissen aktuell
ORF Ö1
AI News Podcast | Latest AI News, Analysis & Events | Daily Inference
AI Daily
Vetenskapsradion
Sveriges Radio
That UFO Podcast
That UFO Podcast
Astronomy Daily: Space News Updates
bitesz.com
Logically Answered
Logically Answered
GraveYard Tales
Adam Ballinger & Matt Rudolph
Weekly Weather Brief
Emily and Kerrin
Psychologie fürs Klassenzimmer
Dr. Benedikt Wisniewski
پادکست مهرانگیز
reza amir
Efervesciencia
Efervesciencia
DayWeather Podcast
DayWeather
Building HVAC Science
Bill Spohn
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
The 365 Days of Astronomy
365DaysOfAstronomy.org
6 Ranch Podcast
James Nash
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Verbal Echo
Monica Martin and Co-Host Sara Rowe
Los Angeles Weather Daily
Fast Foundations
Phoenix Weather Daily
Fast Foundations
San Diego Weather Daily
Fast Foundations
Native Land Pod
iHeartPodcasts and Reasoned Choice
Safe Travels
Safe Travels Media
Talkin' Cotton Podcast
University of Georgia's Cotton Team
San Francisco Weather Daily
Fast Foundations
Trent Loos Podcast
Trent Loos
Authentic Biochemistry
Dr Daniel J. Guerra
AccuWeather Daily
AccuWeather
Beyond the Void: Philosophy & Psychology for the Modern Mind
btv
Space News Today
Bitesz.com | Podcasts
《人性的弱点 》知识分享
终身都要成长
Ciencia
Liam Eves and Ted Trafford
Every trial starts with a number on a slide, patients needed, months allotted, a clean straight line on a chart. Liam and Ted pull that line apart in this episode, starting with Lasagna's Law: the 1970s observation that...
In this episode, Ted opens with a poem that captures the persistent, compounding burden on clinical trial sites: 50-page consents, non-functional tech, poached CRCs, financial holdbacks, and study designs that ask far t...
In this episode, Liam and Ted explore one of the most underexamined problems in clinical trial recruitment: patient motivation is not static. Drawing on real-world experience from a late-night participant funnel audit to...
In the final episode of our three-part series with Jill Fikowski, founder and CEO of Changemark Research + Evaluation, we get into one of the most persistent problems in clinical research: retention.Jill unpacks why part...
In Part 2 of our conversation with Jill Fikowski, founder and CEO of Changemark Research + Evaluation, we get into what good community engagement actually looks like in practice not as a checkbox, but as a core design pr...
Jill Fikowski, founder and CEO of Changemark Research + Evaluation, brings 25+ years of lived and professional experience in substance use and mental health research. In this episode we cover her work on the SALOME trial...
Clinical trials don’t become complex overnight, they get there one added process at a time.In this episode, Ted and Liam break down why the industry is so effective at adding new layers, but rarely takes the time to remo...
A 5 AM wake-up call. A perfectly planned setup. And a moment that never delivered.In this episode, Liam and Ted use a story about a missed “blood moon” to explore a deeper truth in clinical trials: expectations don’t alw...
What does it actually mean to put the patient first?In this episode, Liam and Ted explore the role of empathy and human connection in clinical trials. From rushed pre-screening calls to a powerful story of pausing a cons...
What makes a truly high-performing team?Inspired by the precision of Formula One pit crews, where the difference between winning and losing is measured in milliseconds, Ted and Liam explore what clinical trial teams can ...
In Part 3 of 3, Liam and Ted continue their conversation with Frank Watanabe, CEO of Arcutis Biotherapeutics discussing work-life balance, building social capital, and management vs. leadership.The conversation explores ...
In Part 2 of 3, Liam and Ted continue their conversation with Frank Watanabe, CEO of Arcutis Biotherapeutics, focusing on what it takes to hire and build high-performing teams in high-risk environments.Frank shares how h...
In this episode, Liam and Ted sit down with Frank Watanabe, President and CEO of Arcutis Biotherapeutics, to explore his journey from a Navy officer to a biotech executive and the leadership principles established along ...
A patient in a database is not a patient in a trial. So why do we keep treating feasibility like a headcount?Fresh from a week deep in feasibility work, Liam introduces four characters who show up and cause chaos in almo...
In elite sports, races are often won or lost in the transition, and Liam and Ted argue that the same is true in clinical trials. Drawing on the precision of Olympic relay racing, they make the case that the handoff point...
Using a David Letterman-inspired “Top 10” format, the conversation highlights common feasibility pitfalls faced by sponsors, CROs, and clinical trial sites, including overly complex questionnaires, unrealistic enrollment...
Why do clinical trials struggle even when teams are experienced and well-intentioned?In this episode, Liam and Ted explore why these outcomes are rarely about individual performance and far more often about system-level ...
Eligibility criteria are meant to bring clarity to clinical trials, but in practice, they often do the opposite.In this episode of Innovating Clinical Trials, Liam and Ted unpack how poorly worded, ambiguous, or misalign...
In this episode, Liam and Ted unpack why enrollment behaves more like an operating system rather than a standalone process. They explore the question of ownership, the role sponsors play through protocol design, and how ...
In this episode of Innovating Clinical Trials, Liam and Ted explore why building strong relationships with clinical trial sites requires more than dedicated relationship teams, it requires fixing problems at their source...
Completa el formulario de abajo. Asegúrate de seleccionar tanto País como Géneros.
Envíanos un mensaje abajo. Te responderemos en un plazo de 24 horas.